Showing 1 - 13 results of 13 for search 'Shu-Qun Cheng', query time: 0.34s
Refine Results
-
1
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A prelim... by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Jing-Ya Zhong, Shuang Feng, Qian-Zhi Ni, Qian-Zhi Ni, Hong-Fei Zhu, Wei-Wei Pan, Wei-Wei Pan, Jing-Jing Li, Chao Liang, Hong-Kun Zhou, Yan Meng, Wan Yee Lau, Wan Yee Lau, Shu-Qun Cheng, Shu-Qun Cheng, Shu-Qun Cheng, Shu-Qun Cheng
Published 2023-02-01
Article -
2
Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study by Yu-Qing Zhang, Yu-Qing Zhang, Kang Wang, Jin-Kai Feng, Lu-Yun Yuan, Lu-Yun Yuan, Chao Liang, Yan-Jun Xiang, Xu Wang, Xu Wang, Fei-Fei Mao, Shu-Qun Cheng, Shu-Qun Cheng
Published 2023-05-01
Article -
3
Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol by Jie Shi, Kang Wang, Shuang Feng, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni, Wei-Xing Guo, Jian Zhai, Shu-Qun Cheng
Published 2022-12-01
Article -
4
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treat... by Hong-Fei Zhu, Jin-Kai Feng, Yan-Jun Xiang, Kang Wang, Li-Ping Zhou, Zong-Han Liu, Yu-Qiang Cheng, Jie Shi, Wei-Xing Guo, Shu-Qun Cheng
Published 2023-06-01
Article -
5
Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial by Chong-De Lu, Ya-Bo Jiang, Jin-Kai Feng, Lei Wang, Xu-Biao Wei, Bin Zhou, Xiao-Lu Lin, Wei-Xing Guo, Wan Yee Lau, Shu-Qun Cheng
Published 2023-09-01
Article -
6
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Jin-Kai Feng, Zong-Han Liu, Yun-Feng Shan, Yi-Tao Zheng, Qian-Zhi Ni, Shu-Qun Cheng
Published 2023-10-01
Article -
7
A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study by Zong‐Han Liu, Zong‐Tao Chai, Jin‐Kai Feng, Yu‐Chao Hou, Xiu‐Ping Zhang, Zhen‐Hua Chen, Yan‐Jun Xiang, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Published 2023-05-01
Article -
8
Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence by Yu Jiang Master of Engineering, Kang Wang Master of Medicine, Yu-Ran Wang Master of Engineering, Yan-Jun Xiang Master of Medicine, Zong-Han Liu Doctor of Medicine, Jin-Kai Feng Doctor of Medicine, Shu-Qun Cheng Doctor of Medicine
Published 2023-11-01
Article -
9
Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study by Wei‐Jun Wang, Zong‐Han Liu, Kang Wang, Hong‐Ming Yu, Yu‐Qiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Li‐Ping Zhou, Hong‐Kun Zhou, Wei‐Wei Pan, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Published 2023-05-01
Article -
10
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study by Kang Wang, Zong-Han Liu, Hong-Ming Yu, Yu-Qiang Cheng, Yan-Jun Xiang, Jing-Ya Zhong, Qian-Zhi Ni, Li-Ping Zhou, Chao Liang, Hong-Kun Zhou, Wei-Wei Pan, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng
Published 2023-03-01
Article -
11
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal... by Jin-Kai Feng, Zong-Han Liu, Zhi-Gang Fu, Zong-Tao Chai, Ju-Xian Sun, Kang Wang, Yu-Qiang Cheng, Hong-Fei Zhu, Yan-Jun Xiang, Yan-Jun Xiang, Li-Ping Zhou, Jie Shi, Wei-Xing Guo, Jian Zhai, Shu-Qun Cheng
Published 2022-11-01
Article -
12
Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study by Li-Ming Huang, Zhen-Xin Zeng, Jun-Yi Wu, Jun-Yi Wu, Yi-Nan Li, Jin-Xiu Wang, Yang-Kai Fu, Jia-Yi Wu, Jia-Yi Wu, Shao-Ming Wei, Shao-Ming Wei, Jia-Hui Lv, Wei-Zhao Chen, Rong-Fa Huang, Shu-Qun Cheng, Mao-Lin Yan, Mao-Lin Yan
Published 2023-12-01
Article -
13
PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1 by Yi-Kang Wang, Ning Ma, Sheng Xu, Jing-Yi Huang, Qian-Zhi Ni, Hui-Jun Cao, Qian-Wen Zheng, Bing Zhu, Ji Xia, Feng-Kun Zhang, Xu-Fen Ding, Xiao-Song Qiu, Tian-Wei Chen, Kang Wang, Wei Chen, Zhi-Gang Li, Shu-Qun Cheng, Dong Xie, Jing-Jing Li
Published 2023-04-01
Article